lamivudine has been researched along with Necrosis in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (23.08) | 18.2507 |
| 2000's | 7 (53.85) | 29.6817 |
| 2010's | 3 (23.08) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Azu, OO; Chuturgoon, A; Masia, T; Naidu, EC; Naidu, JS; Nzemande, NF; Singh, S | 1 |
| Chan, SH; Chang, TT; Cheng, PN; Huang, W; Lin, YJ; Su, IJ; Tsai, HW; Wu, HC; Wu, IC; Yen, CJ | 1 |
| Beland, FA; Fang, JL; McGarrity, LJ | 1 |
| Huang, Y; Wang, J; Wang, M | 1 |
| Dienstag, JL; Gardner, S; Goldin, RD; Gray, DF; Hann, HW; Heathcote, EJ; Schiff, ER; Stephenson, SL; Woessner, M | 1 |
| Akarca, US; Batur, Y; Ersoz, G; Gunsar, F; Karasu, Z; Saritas, E; Yuce, G | 1 |
| Akarca, US; Cakaloglu, Y; de Man, RA; Flink, HJ; Janssen, HL; Schalm, SW; Simon, C; So, TM; van Zonneveld, M; Zondervan, PE | 1 |
| Fung, J; Lai, CL; Mizokami, M; Tanaka, Y; Wong, DK; Yuen, MF | 1 |
| Erden, E; Girgin, N; Kansu, A; Krsaçloglu, CT; Kuloglu, Z | 1 |
| Duchatelle, V; Durand, F; Hermine, O; Karras, A; Rabian, C; Valla, D; Viard, JP; Zylberberg, H | 1 |
| Arase, Y; Chayama, K; Ikeda, K; Kobayashi, M; Koike, M; Kumada, H; Ogawa, N; Saitoh, S; Suzuki, Y; Tanikawa, K; Tsubota, A | 1 |
| Clouston, AD; Crawford, DH; Hourigan, LF; Maguire, CM; Powell, EE; Walpole, ET | 1 |
| Chi, JG; Jang, JJ; Kim, CY; Kim, JW; Lee, HS; Woo, GH; Yoon, JH | 1 |
5 trial(s) available for lamivudine and Necrosis
| Article | Year |
|---|---|
Histological outcome during long-term lamivudine therapy.
Topics: Adult; Alanine Transaminase; Disease Progression; DNA, Viral; Drug Administration Schedule; Female; Genetic Variation; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Liver; Liver Cirrhosis; Male; Necrosis; Reverse Transcriptase Inhibitors; Safety | 2003 |
Interferon-lamivudine combination is no better than lamivudine alone in anti-HBe-positive chronic hepatitis B.
Topics: Adult; Aged; Alanine Transaminase; Antiviral Agents; DNA, Viral; Drug Administration Schedule; Drug Therapy, Combination; Female; Fibrosis; Hepatitis B Antibodies; Hepatitis B, Chronic; Humans; Interferon-alpha; Lamivudine; Liver; Male; Middle Aged; Necrosis; Remission Induction; Reverse Transcriptase Inhibitors; Time Factors | 2004 |
Peg-interferon improves liver histology in patients with HBeAg-positive chronic hepatitis B: no additional benefit of combination with lamivudine.
Topics: Adult; Alanine Transaminase; Antiviral Agents; Biopsy; Disease Progression; Double-Blind Method; Drug Therapy, Combination; Female; Hepatitis B e Antigens; Hepatitis B, Chronic; Humans; Inflammation; Interferon alpha-2; Interferon-alpha; Lamivudine; Liver; Liver Cirrhosis; Male; Middle Aged; Necrosis; Polyethylene Glycols; Recombinant Proteins | 2006 |
Liver histology of children with chronic hepatitis treated with interferon-alpha alone or in combination with lamivudine.
Topics: Adolescent; Anti-HIV Agents; Antiviral Agents; Biopsy; Child; Child, Preschool; Drug Therapy, Combination; Female; Follow-Up Studies; Hepatitis, Chronic; Humans; Interferon-alpha; Lamivudine; Liver; Male; Necrosis; Prospective Studies; Treatment Outcome | 2007 |
Histological changes in liver biopsies after one year of lamivudine treatment in patients with chronic hepatitis B infection.
Topics: Adult; Antiviral Agents; Biopsy; DNA, Viral; Female; Follow-Up Studies; Hepatitis B e Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Inflammation; Lamivudine; Liver; Male; Necrosis; Observer Variation; Time Factors | 1999 |
8 other study(ies) available for lamivudine and Necrosis
| Article | Year |
|---|---|
Testicular histomorphologic and stereological alterations following short-term treatment with highly active antiretroviral drugs (HAART) in an experimental animal model.
Topics: alpha-Tocopherol; Animals; Anti-HIV Agents; Antioxidants; Antiretroviral Therapy, Highly Active; Ascorbic Acid; Atrophy; Lamivudine; Male; Models, Animal; Necrosis; Nevirapine; Random Allocation; Rats; Rats, Sprague-Dawley; Seminiferous Tubules; Stavudine | 2014 |
Resistance of ground glass hepatocytes to oral antivirals in chronic hepatitis B patients and implication for the development of hepatocellular carcinoma.
Topics: Adenine; Administration, Oral; Adolescent; Adult; Amino Acid Sequence; Antiviral Agents; Biopsy; Carcinoma, Hepatocellular; DNA, Circular; Drug Resistance, Viral; Fatty Liver; Female; Guanine; Hepatitis B Surface Antigens; Hepatitis B virus; Hepatitis B, Chronic; Hepatocytes; Humans; Lamivudine; Liver; Liver Neoplasms; Male; Middle Aged; Necrosis; Organophosphonates; Protein Precursors; Sequence Deletion; Viral Load; Young Adult | 2016 |
Interference of cell cycle progression by zidovudine and lamivudine in NIH 3T3 cells.
Topics: Animals; Blotting, Western; Bromodeoxyuridine; Cell Cycle; Cell Cycle Proteins; Cell Death; Cell Proliferation; Cell Survival; DNA; Flow Cytometry; Lamivudine; Mice; Necrosis; NIH 3T3 Cells; Zidovudine | 2009 |
Acute liver failure resulting from discontinuation of nucleoside analogues in chronic hepatitis B patients: a report of two cases.
Topics: Adenine; Adult; Antiviral Agents; Guanine; Hepatitis B, Chronic; Histocytochemistry; Humans; Lamivudine; Liver Failure, Acute; Liver Transplantation; Male; Medication Adherence; Necrosis; Organophosphonates; Telbivudine; Thymidine | 2013 |
Hepatitis B virus core-related antigens as markers for monitoring chronic hepatitis B infection.
Topics: Adult; DNA, Viral; Enzyme-Linked Immunosorbent Assay; Female; Guanine; Hepatitis B Core Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Liver; Liver Cirrhosis; Luminescent Measurements; Male; Middle Aged; Necrosis; Statistics as Topic | 2007 |
Severe anoxic hepatic necrosis in an HIV-1-hepatitis C virus-co-infected patient starting antiretroviral triple combination therapy.
Topics: Adult; AIDS-Related Opportunistic Infections; Anti-HIV Agents; Drug Therapy, Combination; Hepatitis C; HIV Protease Inhibitors; HIV-1; Humans; Indinavir; Lamivudine; Male; Necrosis; Red-Cell Aplasia, Pure; Reverse Transcriptase Inhibitors; Zidovudine | 1998 |
Case report: lamivudine therapy for submassive hepatic necrosis due to reactivation of hepatitis B following chemotherapy.
Topics: Antineoplastic Agents; Antiviral Agents; Breast Neoplasms; Female; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Liver; Middle Aged; Necrosis; Reverse Transcriptase Inhibitors; Virus Activation | 1999 |
Fatal submassive hepatic necrosis associated with tyrosine-methionine-aspartate-aspartate-motif mutation of hepatitis B virus after long-term lamivudine therapy.
Topics: Amino Acid Motifs; Antiviral Agents; Drug Resistance, Microbial; Fatal Outcome; Hepatitis B virus; Hepatitis B, Chronic; Humans; Immunocompetence; Lamivudine; Male; Middle Aged; Mutation; Necrosis; Polymorphism, Restriction Fragment Length; Reverse Transcriptase Inhibitors | 2001 |